Rajeev Lall

Rajeev Lall

Active Director Whole-Time Director DIN 01683945
DIN 01683945 First appointment Feb 2002 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2002
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajeev Lall

Data last updated:

Rajeev Lall is a Whole-Time Director at Quantum Biotech Private Limited (since 2002). The company operates in Chemicals.

DIN 01683945
Primary Designation Whole-Time Director
Industry Chemicals
First Appointment 21 Feb 2002
Oldest Company Age 24 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Quantum Biotech Private Limited U24231GJ2002PTC040493
Whole-Time Director21 Feb 20022002Active

Board colleagues of Rajeev Lall

NameDINCompanyDesignation
Anil Kumar00487315Quantum Biotech Private LimitedDirector
Poonam Verma03507687Quantum Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Quantum Biotech Private Limited
Premium access

Shareholding and investment profile for Rajeev Lall

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajeev Lall

Rajeev Lall currently holds 1 directorship: Quantum Biotech Private Limited (Whole-Time Director, since 21 Feb 2002).

Rajeev Lall was first appointed on 21 Feb 2002 as Whole-Time Director at Quantum Biotech Private Limited.

The current boards of Rajeev Lall's companies include Anil Kumar (Quantum Biotech Private Limited), Poonam Verma (Quantum Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available